Rubin Marc
Insider CIK 1412377 · CRIS Director · GALT Director · TTNP.OB Executive Chairman, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRIS CURIS INC | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| CRIS CURIS INC | C Conversion deriv | 2026-03-20 | 2026-03-23 | 20 | — | $0 | 0 | SEC↗ |
| CRIS CURIS INC | C Conversion | 2026-03-20 | 2026-03-23 | 26,667 | — | $0 | 28,108 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 20 | — | $0 | 20 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2023-01-26 | 2023-01-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2022-01-24 | 2022-01-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2022-01-05 | 2022-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2021-03-25 | 2021-03-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2021-03-25 | 2021-03-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2021-02-10 | 2021-02-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2020-01-09 | 2020-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2019-04-02 | 2019-04-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise deriv | 2019-02-22 | 2019-02-25 | 859 | — | $0 | 33,065 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2019-02-22 | 2019-02-25 | 859 | $6.02 | $5.2K | 13,581 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise | 2019-02-22 | 2019-02-25 | 859 | $2.39 | $2.1K | 14,440 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise deriv | 2019-02-21 | 2019-02-25 | 43,326 | — | $0 | 33,924 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2019-02-21 | 2019-02-25 | 7,000 | $6.00 | $42.0K | 13,581 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise | 2019-02-21 | 2019-02-25 | 43,326 | $2.39 | $103.5K | 56,907 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2019-02-21 | 2019-02-25 | 43,326 | $6.02 | $260.8K | 13,581 | SEC↗ |
| CRIS CURIS INC | S Sale | 2019-01-23 | 2019-01-25 | 18,500 | $1.05 | $19.4K | 28,819 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2019-01-16 | 2019-01-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2018-09-21 | 2018-09-25 | 400,000 | — | $0 | 400,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2018-09-21 | 2018-09-25 | 400,000 | $0.25 | $100.0K | 556,317 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise deriv | 2018-09-04 | 2018-09-06 | 6,000 | — | $0 | 16,500 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise | 2018-09-04 | 2018-09-06 | 6,000 | — | $0 | 32,481 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2018-09-04 | 2018-09-06 | 11,900 | $6.58 | $78.3K | 20,581 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise deriv | 2018-08-30 | 2018-09-04 | 29,000 | — | $0 | 22,500 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2018-08-30 | 2018-09-04 | 58,100 | $6.08 | $353.2K | 26,481 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | M Exercise | 2018-08-30 | 2018-09-04 | 29,000 | — | $0 | 84,581 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2018-03-07 | 2018-03-09 | 170,000 | — | $0 | 170,000 | SEC↗ |
| CRIS CURIS INC | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 236,596 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2017-12-14 | 2017-12-18 | 77,250 | — | $0 | 77,250 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | P Buy | 2017-12-08 | 2017-12-08 | 7,000 | $1.85 | $12.9K | 55,581 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | P Buy | 2017-12-08 | 2017-12-08 | 7,000 | $1.85 | $12.9K | 55,581 | SEC↗ |
| CRIS CURIS INC | P Buy | 2017-11-16 | 2017-11-16 | 25,000 | $0.98 | $24.5K | 51,596 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2017-02-13 | 2017-02-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2016-12-15 | 2016-12-19 | 51,500 | — | $0 | 51,500 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2016-02-02 | 2016-02-02 | 79,100 | — | $0 | 79,100 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2016-01-11 | 2016-01-11 | 5,000 | $3.25 | $16.3K | 156,317 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2015-12-14 | 2016-02-02 | 90,900 | — | $0 | 90,900 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award deriv | 2015-12-14 | 2015-12-16 | 170,000 | — | $0 | 170,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2015-08-28 | 2015-08-31 | 50,000 | $0.72 | $36.0K | 832,200 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-05-21 | 2015-07-08 | 2,768 | — | $0 | 48,581 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | D To issuer deriv | 2015-04-08 | 2015-07-08 | 16,714 | — | $0 | 0 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | D To issuer deriv | 2015-04-08 | 2015-07-08 | 16,495 | — | $0 | 0 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-04-08 | 2015-07-08 | 28,367 | — | $0 | 45,813 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award deriv | 2015-03-16 | 2015-03-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-03-12 | 2015-07-08 | 11,112 | — | $0 | 17,446 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | P Buy | 2014-10-09 | 2014-10-14 | 100,000 | $0.48 | $48.0K | 707,200 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award | 2014-02-12 | 2014-02-14 | 100,000 | $0.66 | $66.0K | 682,200 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | P Buy | 2013-12-04 | 2013-12-04 | 3,000 | $8.69 | $26.1K | 6,334 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | P Buy | 2013-06-17 | 2013-06-19 | 50,000 | $0.45 | $22.5K | 463,400 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2013-03-28 | 2013-04-01 | 16,714 | — | $0 | 16,714 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2013-01-17 | 2013-01-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2012-01-05 | 2012-01-06 | 50,000 | — | $0 | 25,000 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award deriv | 2012-01-03 | 2012-01-05 | 250,000 | — | $0 | 250,000 | SEC↗ |